News

First subject enrolled in trial of Medtronic’s liquid embolic system
Medtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to ...
Investor's Business Daily on MSN17h
Dow's J&J Surges; Why Its Report Is Also Bullish For Stryker, Medtronic, Boston Scientific
Johnson & JohnsonJNJ stock jumped Wednesday after the Dow Jones health behemoth raised its 2025 guidance in the wake of a bullish second-quarter report.For the year, J&J now expects adjusted earnings ...
MassDevice19h
Medtronic enrolls first patient in study for Onyx liquid embolic system
Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).
Medical Design & Outsourcing21h
With Medtronic’s next-gen RDN devices and procedures advancing, Project Galileo is next
Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...
MedTech Dive21h
‘We are not rolling over’: J&J electrophysiology unit rebounds amid PFA rivalry
J&J’s electrophysiology group returned to growth in the second quarter after a decline in the prior quarter. Now, can the ...